@inproceedings{inproceedings, title = {{The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.}}, url = {{}}, year = {{2003}}, month = {{9}}, author = {{Bansback NJ and Brennan A and Ghatnekar O and Sengupta N and Chang KY and Hansen M}}, volume = {{48}}, journal = {{ARTHRITIS AND RHEUMATISM}}, issue = {{9}}, pages = {{S611-S611}}, note = {{Accessed on 2025/05/20}}}